NCT03518645

Brief Summary

Study aim : To compare a novel strategy of lesion preparation with noncompliant balloons before implantation of BVS. Hypothesis: Predilatation with non-compliant balloons could facilitate optimal deployment of BVS. By achieving good scaffold apposition a need for post-dilatation could be significantly reduced. This is expected to result in better short- and long-term outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2015

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 20, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 8, 2018

Completed
Last Updated

May 8, 2018

Status Verified

May 1, 2018

Enrollment Period

1.8 years

First QC Date

April 20, 2018

Last Update Submit

May 7, 2018

Conditions

Keywords

Coronary Artery DiseaseOPN NCAnginaStableUnstable

Outcome Measures

Primary Outcomes (1)

  • Apposition of bioresorbable scaffold immediately after stent implantation following: pre-dilatation with OPN vs. pre-dilatation with standard balloons.

    Stent apposition will be assessed based on OCT (optical coherence tomography) visualization.

    During the index procedure

Secondary Outcomes (8)

  • Procedural success defined as successful delivery of the scaffold.

    During the index procedure

  • Need for post-dilatation after initial OCT.

    During the index procedure

  • Scaffold apposition after post-dilatation.

    During the index procedure

  • Periprocedural complications: dissection, slow- or no flow, dissection requiring additional stent implantation.

    During the index procedure

  • Periprocedural myocardial infarction defined as 5x upper reference level elevation of high sensitive Troponin I (in patients with normal pre-procedural Troponin).

    During the index procedure

  • +3 more secondary outcomes

Study Arms (2)

OPN strategy

EXPERIMENTAL

The OPN NC Super High Pressure PTCA Balloon will be used as the study device for lesion preparation for BVS Absorb implantation - OPN strategy of lesion preparation. This balloon has a twin layer balloon construction, which allows a very high pressure resistance of 35 bar. The balloon has a 0.016'' lesion entry profile and is available in sizes between 1.5 and 4.5 mm and lengths of 10, 15 and 20 mm.

Device: OPN strategy

standard strategy

ACTIVE COMPARATOR

Predilatation with standard coronary balloon will be performed for lesion preparation for BVS Absorb implantation - standard strategy of lesion preparation.

Device: standard strategy

Interventions

Predilatation with OPN balloon will be performed as a lesion preparation for BVS Absorb implantation.

OPN strategy

Predilatation with standard balloon will be performed as a lesion preparation for BVS Absorb implantation.

standard strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years.
  • Able and willing to give informed consent.
  • Willing to comply with specified follow-up evaluations.
  • Clinical manifestation of coronary artery disease: stable angina, unstable angina or non-ST-elevation myocardial infarction.
  • De novo lesion.
  • Angiographic diameter stenosis \> 70 % and/or fractional flow reserve \<0.80.
  • Vessel diameter between 2.5 and 4.0 mm.
  • One- or two vessel disease (defined as diameter stenosis \> 70 % in vessels with a diameter \> 2.5 mm).
  • Up to two lesions in one or two vessels can be treated.

You may not qualify if:

  • Patient characteristics
  • Pregnant or nursing patient or planned pregnancy in the period up to 1 year following the index procedure.
  • Patient with contraindication for 12 months of dual antiplatelet therapy.
  • ST-elevation myocardial infarction.
  • Any contraindication to the implantation of BVS. Lesion characteristics
  • Visible thrombus in coronary angiography
  • Chronic total occlusion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luzerner Kantonsspital

Lucerne, Switzerland

Location

Related Publications (1)

  • Cuculi F, Bossard M, Zasada W, Moccetti F, Voskuil M, Wolfrum M, Malinowski KP, Toggweiler S, Kobza R. Performing percutaneous coronary interventions with predilatation using non-compliant balloons at high-pressure versus conventional semi-compliant balloons: insights from two randomised studies using optical coherence tomography. Open Heart. 2020 Jan 23;7(1):e001204. doi: 10.1136/openhrt-2019-001204. eCollection 2020.

MeSH Terms

Conditions

Coronary Artery DiseaseAngina, UnstableAngina, StableAngina Pectoris

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Florim Cuculi, MD, PhD

    Luzerner Kantonsspital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 20, 2018

First Posted

May 8, 2018

Study Start

March 1, 2015

Primary Completion

December 1, 2016

Study Completion

March 29, 2018

Last Updated

May 8, 2018

Record last verified: 2018-05

Locations